Home › Lupus Nephritis › NCT07783152
Lupus Nephritis Care Pathway
Evaluation of a Lupus Nephritis Care Pathway Integrating Telemedicine and Clinical Pharmacist Practitioners
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Active patient at a Duke University Health System clinic * Current diagnosis of Systemic Lupus Erythematosus (SLE) based on the 1997 ACR,32 2012 Systemic Lupus International Collaborating Clinics (SLICC),33 or 2019 European League Against Rheumatism (EULAR)/ACR (American College of Rheumatology)34 classification criteria * Aged 18 years or older * Able to provide informed consent * Able to attend telemedicine visits * New onset or ongoing active LN based on rheumatologist or nephrologist evaluation Exclusion Criteria: * Patients with severe cognitive impairment * Do not wish to receive longitudinal care at our health system
About the study
The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 patients. Activities include answering surveys and participating in an interview.
Objectives include: 1) Assess feasibility and acceptability of the LN Care Pathway, 2) evaluate user experiences to identify opportunities for improvement, and 3) explore the preliminary effect of this pathway on medication adherence and clinical outcomes.
What is being tested
- Lupus Nephritis (LN) Care Pathway (behavioral)
Sponsor: Duke University · Participants: 25 · Started: Oct 14, 2026
Contact the study team
- Edna Scarlett · Phone: 919-684-6150
Official record on ClinicalTrials.gov — NCT07783152
Locations in the U.S.
| North Carolina | Duke University, Durham |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.